Brilique 90 mg
Brilique 90 mg is a medicine authorised by Swissmedic under authorisation number 61389. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 June 2011 and the authorisation is valid without a time limit. ATC code B01AC24 places the medicine in the group Antithrombotic agents.
| Authorisation number | 61389 |
|---|---|
| Name | Brilique 90 mg |
| Full name | Brilique 90 mg, Filmtabletten |
| Authorisation holder | AstraZeneca AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B01AC24 |
| First authorisation | 30 June 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Brilique 90 mg, Filmtabletten | B | 30 June 2011 |
| 2 | Brilique 60 mg, Filmtabletten | B | 19 September 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 2 | 100 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 3 | 168 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 4 | 56 | Tablette(n) | B01AC24 | 06.03.2. | B |
| 5 | 168 | Tablette(n) | B01AC24 | 06.03.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Brilique 90 mg authorised in Switzerland?
Yes. Brilique 90 mg is authorised by Swissmedic under authorisation number 61389, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Brilique 90 mg have?
Brilique 90 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Brilique 90 mg?
The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.